Bao Fang, Liu Jiayue, Chen Haiyang, Miao Lu, Xu Zhaochao, Zhang Guixin
Institute of Integrative Medicine, Dalian Medical University, No. 9, South Road of Lvshun, Dalian 116044, China.
Department of General Surgery, Pancreatic-Biliary Center, The First Affiliated Hospital of Dalian Medical University, No. 222, Zhongshan Road, Dalian 116011, China.
Cancers (Basel). 2022 Aug 13;14(16):3921. doi: 10.3390/cancers14163921.
Cholangiocarcinoma (CCA) is a multifactorial malignant tumor of the biliary tract, and the incidence of CCA is increasing in recent years. At present, the diagnosis of CCA mainly depends on imaging and invasive examination, with limited specificity and sensitivity and late detection. The early diagnosis of CCA always faces the dilemma of lacking specific diagnostic biomarkers. Non-invasive methods to assess the degree of CAA have been developed throughout the last decades. Among the many specimens looking for CCA biomarkers, bile has gotten a lot of attention lately. This paper mainly summarizes the recent developments in the current research on the diagnostic biomarkers for CCA in human bile at the levels of the gene, protein, metabolite, extracellular vesicles and volatile organic compounds.
胆管癌(CCA)是一种多因素导致的胆道恶性肿瘤,近年来CCA的发病率呈上升趋势。目前,CCA的诊断主要依赖于影像学检查和侵入性检查,其特异性和敏感性有限,且发现较晚。CCA的早期诊断一直面临缺乏特异性诊断生物标志物的困境。在过去几十年中,已经开发出了评估CCA程度的非侵入性方法。在众多寻找CCA生物标志物的标本中,胆汁最近受到了广泛关注。本文主要从基因、蛋白质、代谢产物、细胞外囊泡和挥发性有机化合物等层面,总结了目前人类胆汁中CCA诊断生物标志物研究的最新进展。